Shiga Toxins Produced by Enterohaemorrhagic Escherichia coli Induce Inflammation in Toxin-Sensitive Cells through the p38 MAPK/MK2/Tristetraprolin Signaling Pathway
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Shiga toxins (Stxs), produced by Shigella dysenteriae serotype 1 and certain Escherichia coli pathotypes, cause hemorrhagic colitis, which can progress to hemolytic uremic syndrome (HUS) and central nervous system (CNS) pathology. The underlying mechanisms of toxin-induced inflammation remain unclear. The p38 mitogen-activated protein kinase (MAPK) and its downstream target, MAPKAPK2 (MK2), play key roles in various cellular responses. We identified Tristetraprolin (TTP) as a novel substrate of MK2 in Stx-intoxicated cells. Western blot analysis showed that Stxs induce phosphorylation of MK2 (Thr334) and TTP in globotriaosylceramide (Gb3)-positive cells, including DTHP-1 macrophage-like cells and HK-2 renal epithelial cells, but not in Gb3-negative T84 colon carcinoma cells. After treatment with wild-type Stx, the activity of phosphorylated MK2 and TTP persists for up to 8 h, while Stx2amut, which lacks N-glycosidase activity, causes transient MK2/TTP phosphorylation. This suggests that Stxs selectively mediate MK2 and TTP activation in a Gb3- dependent manner. Knockdown of TTP in Stx2a-treated D-THP-1 cells upregulates proinflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-8, MCP-1, and MIP-1α. The MK2 inhibitor PF-3644022 significantly reduces TTP phosphorylation and blocks the production of IL-6, IL-8, MCP-1, and MIP1α in Stx2a-stimulated HK-2 cells. In conclusion, the MK2-TTP signaling pathway regulates the inflammatory response induced by Stxs in toxin-sensitive cells.
Abstract
Shiga toxins (Stxs), produced by Shigella dysenteriae serotype 1 and certain Escherichia coli pathotypes, cause hemorrhagic colitis, which can progress to hemolytic uremic syndrome (HUS) and central nervous system (CNS) pathology. The underlying mechanisms of toxin-induced inflammation remain unclear. The p38 mitogen-activated protein kinase (MAPK) and its downstream target, MAPKAPK2 (MK2), play key roles in various cellular responses. We identified Tristetraprolin (TTP) as a novel substrate of MK2 in Stx-intoxicated cells. Western blot analysis showed that Stxs induce phosphorylation of MK2 (Thr334) and TTP in globotriaosylceramide (Gb3)-positive cells, including DTHP-1 macrophage-like cells and HK-2 renal epithelial cells, but not in Gb3-negative T84 colon carcinoma cells. After treatment with wild-type Stx, the activity of phosphorylated MK2 and TTP persists for up to 8 h, while Stx2amut, which lacks N-glycosidase activity, causes transient MK2/TTP phosphorylation. This suggests that Stxs selectively mediate MK2 and TTP activation in a Gb3- dependent manner. Knockdown of TTP in Stx2a-treated D-THP-1 cells upregulates proinflammatory cytokines such as TNF-α, IL-1β, IL-6, IL-8, MCP-1, and MIP-1α. The MK2 inhibitor PF-3644022 significantly reduces TTP phosphorylation and blocks the production of IL-6, IL-8, MCP-1, and MIP1α in Stx2a-stimulated HK-2 cells. In conclusion, the MK2-TTP signaling pathway regulates the inflammatory response induced by Stxs in toxin-sensitive cells.
참고문헌 (38)
- Cody EM, "Hemolytic uremic syndrome", Pediatr. Clin. North Am, 66, pp.235~246 (2019)
- Johannes L, "Shiga toxins--from cell biology to biomedical applications", Nat. Rev. Microbiol, 8, pp.105~116 (2010)
- Travert B, "Shiga toxin-associated hemolytic uremic syndrome : specificities of adult patients and implications for critical care management", Toxins(Basel), 13, pp.306~ (2021)
- Freedman SB, "Shiga toxin-producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome : a meta-analysis", Clin. Infect. Dis, 62, pp.1251~1258 (2016)
- Majowicz SE, "Global incidence of human Shiga toxinproducing Escherichia coli infections and deaths : a systematic review and knowledge synthesis", Foodborne Pathog. Dis, 11, pp.447~455 (2014)
- Gould LH, "Recommendations for diagnosis of shiga toxin--producing Escherichia coli infections by clinical laboratories", MMWR Recomm. Rep, 58, pp.1~14 (2009)
- Muthing J, "Promiscuous Shiga toxin 2e and its intimate relationship to Forssman", Glycobiology, 22, pp.849~862 (2012)
- Villysson A, "Microvesicle involvement in Shiga toxin-associated infection", Toxins(Basel), 9, pp.376~ (2017)
- Henrique IM, "Therapeutic antibodies against Shiga toxins : trends and perspectives", Front. Cell. Infect. Microbiol, 12, pp.825856~ (2022)
- Bai X, "Identification and pathogenomic analysis of an Escherichia coli strain producing a novel Shiga toxin 2 subtype", Sci. Rep, 8, pp.6756~ (2018)
- Yang X, "Escherichia coli strains producing a novel Shiga toxin 2 subtype circulate in China", Int. J. Med. Microbiol, 310, pp.151377~ (2020)
- Panel EB, "Pathogenicity assessment of Shiga toxin-producing Escherichia coli(STEC)and the public health risk posed by contamination of food with STEC", EFSA J, 18, pp.e05967~ (2020)
- Cooling LL, "Shiga toxin binds human platelets via globotriaosylceramide(Pk antigen)and a novel platelet glycosphingolipid", Infect. Immun, 66, pp.4355~4366 (1998)
- Menge C, "Molecular Biology of Escherichia coli Shiga toxins' effects on Mammalian cells", Toxins(Basel), 12, pp.345~ (2020)
- Kavaliauskiene S, "Protection against Shiga toxins", Toxins(Basel), 9, pp.44~ (2017)
- Lee MS, "Roles of Shiga toxins in immunopathology", Toxins(Basel), 11, pp.212~ (2019)
- Leyva-Illades D, "Regulation of cytokine and chemokine expression by the ribotoxic stress response elicited by Shiga toxin type 1 in human macrophage-like THP-1 cells", Infect. Immun, 80, pp.2109~2120 (2012)
- Saenz JB, "The MAP kinase-activated protein kinase 2(MK2)contributes to the Shiga toxin-induced inflammatory response", Cell. Microbiol, 12, pp.516~529 (2010)
- Stokoe D, "Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins", FEBS Lett, 313, pp.307~313 (1992)
- Clement SL, "Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment", Mol. Cell. Biol, 31, pp.256~266 (2011)
- Patial S, "Tristetraprolin as a therapeutic target in inflammatory disease", Trends Pharmacol. Sci, 37, pp.811~821 (2016)
- Ronkina N, "The role of TTP phosphorylation in the regulation of inflammatory cytokine production by MK2", 3, 2019, pp.203, 2291~2300
- O'Neil JD, "MAPK p38 regulates inflammatory gene expression via tristetraprolin : doing good by stealth", Int. J. Biochem. Cell. Biol, 94, pp.6~9 (2018)
- Kim MS, "Intestinal anti-inflammatory effects of cinnamon extracts in a co-culture model of intestinal epithelial Caco-2 cells and RAW264.7 macrophages", Appl. Biol. Chem, 60, pp.553~561 (2017)
- Shivakumar S, "Chloroquine protects human corneal epithelial cells from desiccation stress induced inflammation without altering the autophagy flux", Biomed. Res. Int, 2018, pp.7627329~ (2018)
- Stearns-Kurosawa DJ, "Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic Escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome", Am. J. Pathol, 182, pp.1227~1238 (2013)
- Staples KJ, "IL-10 induces IL-10 in primary human monocytederived macrophages via the transcription factor Stat3", J. Immunol, 178, pp.4779~4785 (2007)
- Haga H, "Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth", J. Extracell. Vesicles, 4, pp.24900~ (2015)
- Abubaker J, "DNAJB3", HSP-40 cochaperone is downregulated in obese humans and is restored by physical exercise, 2013, pp.8, e69217~
- Ben-Levy R, "Identification of novel phosphorylation sites required for activation of MAPKAP kinase-2", EMBO J, 14, pp.5920~5930 (1995)
- Qiu LQ, "Myeloid-specific tristetraprolin deficiency in mice results in extreme lipopolysaccharide sensitivity in an otherwise minimal phenotype", J. Immunol, 188, pp.5150~5159 (2012)
- Prabhala P, "Temporal regulation of cytokine mRNA expression by tristetraprolin : dynamic control by p38 MAPK and MKP-1", Am. J. Physiol. Lung Cell. Mol. Physiol, 308, pp.L973~980 (2015)
- Rahman MM, "Activating protein phosphatase 2A(PP2A)enhances tristetraprolin(TTP)anti-inflammatory function in A549 lung epithelial cells", Cell. Signal, 28, pp.325~334 (2016)
- Haneklaus M, "The RNA-binding protein Tristetraprolin(TTP)is a critical negative regulator of the NLRP3 inflammasome", J. Biol. Chem, 292, pp.6869~6881 (2017)
- Carballo E, "Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin", Science, 281, pp.1001~1005 (1998)
- Hsieh HH, "The functional characterization of phosphorylation of tristetraprolin at C-terminal NOT1-binding domain", J. Inflamm(Lond), 18, pp.22~ (2021)
- McGuire VA, "Cross talk between the Akt and p38alpha pathways in macrophages downstream of Toll-like receptor signaling", Mol. Cell. Biol, 33, pp.4152~4165 (2013)
- Mourey RJ, "A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation", J. Pharmacol. Exp. Ther, 333, pp.797~807 (2010)